<PAGE> 1
[WILSON SONSINI GOODRICH & ROSATI LETTERHEAD]
October 28, 1996
VIA EDGAR
Mr. Tom Jones
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attn: Filing Desk, Mail Stop 1-4
Re: Introgen Therapeutics, Inc.
Registration Statement on Form 8-A
Dear Mr. Jones:
On behalf of Introgen Therapeutics, Inc., a Delaware corporation (the
"Company"), we hereby withdraw the Company's Registration Statement on Form 8-A
filed with the Commission on September 3, 1996 in order to prevent the 8-A from
taking effect prior to the Company's S-1.
Please contact Marnia Nichols of our office or me with any questions or
comments that you have.
Very truly yours,
WILSON SONSINI GOODRICH & ROSATI
Professional Corporation
/s/ WILLIAM B. OWENS, JR.
William B. Owens, Jr.
cc: Abe Zachariah
David Nance
Irene Mavroyannis